Magnetic bead technology for viral RNA extraction from serum in blood bank screening

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages 547-552

  Albertoni, Guilherme Ambrozio ^a   Arnoni, Carine Prisco ^a   Barboza Araujo, Patricia Regina ^a   Andrade, Sheila Siqueira ^a   Carvalho, Fabrício Oliveira ^a   Castello Girão, Manoel João Batista ^a   Schor, Nestor ^b   Barreto, José Augusto ^a  

^a Laboratório de Espectrometria de Massas Associação Beneficente de Coleta de Sangue   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood banks; HCV; HIV; Infection; Reverse transcriptase polymerase chain reaction

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAFETY; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAGNETIC BEAD TECHNOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; RNA EXTRACTION; SCREENING TEST; SEROLOGY; VIRUS DETECTION; VIRUS TRANSMISSION;

BLOOD BANKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MAGNETICS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PARTICLE SIZE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84855954694     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70249-5     Document Type: Article

References (27)

1. Alter H.J., Houghton M. Hepatitis C virus and eliminating post transfusion hepatitis. Nat Med 2000, 6:1082-1086.
2. Stramer S.L., Glynn S.A., Kleinman S.H., et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004, 351:760-768.
3. Roth W.K., Weber M., Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999, 53:359-363.
4. Laperche S. Blood safety and nucleic acid testing in Europe. Euro Survey 2005, 10:3-4.
5. Coste J., Reesink H.W., Engelfriet C.P., Laperche S. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. Vox Sang 2005, 88:289-303.
6. Velati C., Fomiatti L., Baruffi L., Romano L., Zanetti A. Impact of nucleic acid amplification technology (NAT) in Italy in the three years folowing implementation (2001-2003). Euro Surveill 2005, 10:12-14.
7. Jackson B.R., Busch M.O., Stramer S.L., AuBuchon J.P. The costeffectiveness of NAT for HIV, HCV and HBV in whole-blood donations. Transfusion 2003, 43:721-729.
8. Roth W.K., Buhr S., Drosten C., Seifried E. NAT and viral safety in blood transfusion. Vox Sang 2000, 78(Suppl):257-259.
9. Braham S., Gandhi J., Beard S., Cohen B. Evaluation of the Roche lightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections. J Clin Virol 2004, 31:5-10.
10. Allain J.P. Transfusion risks of yesterday and of today. Transfus Clin Biol 2003, 10:1-5.
11. Sabino E.C., Salles N.A., Sáez-Alquezar A., Santos G.R., Chamone D.F., Busch M.P. Estimated risk of transfusion-transmitted HIV infection in São Paulo. Brazil. Transfusion 1999, 39:1152-1153.
12. Wendel S., Fachini R.M., Levi J.E., et al. A single window-period donation detected by human immunodeficiency vírus p24 antigen after 5 years of routine screening in a group of Brazilian blood banks. Vox Sang 2002, 83:309-312.
13. Barreto C.C., Sabino E.C., Gonçalvez T.T., et al. Prevalence, incidence and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion 2005, 45:1709-1714.
14. Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Especializada, Coordenação Geral de Sangue e Hemoderivados. Estágio Atual da Implantação dos Testes de ácido Nucléico para HIV e HCV - NAT HIV/HCV na rede de Serviços de Hemoterapia do Brasil. Nota técnica, 2010.
15. Hourfar M.K., Schimidt M., Seifried E., Roth W.K. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment. Vox Sang 2005, 89:71-76.
16. Fleiss J.L. Statistical methods for rates and proportion 1981, John Wiley & Sons, New York, 212-25. 2nd ed.
17. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
18. Gerberding J.L., Fleming D.W., Snider D.E. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Epidemiology Program Office, Centers for Disease control and Prevention (CDC), Department of Health and Human Services 2003, 52:1-15.
19. Boom R., Sol J.C.R., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., Van Der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990, 28:495-503.
20. Vogelstein B., Gillespie D. Preparative and purification of DNA from agarose. Proc Natl Acad Sci USA 1979, 76:615-669.
21. Castellino F.J., Barker R. The denaturing effectiveness of guanidinium, carbamoylguanidinium, and guanylguanidinium salts. Biochemistry 1968, 7:4135-4138.
22. Chirgwin J.M., Przbyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979, 8:5294-5299.
23. Melzak K.A., Sherwood C.S., Turner R.F.B., Haynes C.A. Driving forces for DNA adsorption to silica in perchlorate solutions. J Colloid Interface Sci 1996, 181:635-644.
24. Pichl L., Heitmann A., Herzog P., Oster J., Smets H., Schottstedt V. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools. Transfusion 2005, 45:1106-1110.
25. Hourfar M.K., Michelsen U., Schmidt M., Berger A., Seifried E., Roth W.K. High-throughput purification of viral RNA based on novel aqueous chemistry for nucleic acid isolation. Clin Chemistry 2005, 7:1217-1222.
26. Jarvis L., Becker J., Tender A., et al. Evaluation of the Roche cobas 201 system and cobas TaqScreen multiplex test for blood screening: European multicenter study. Transfusion 2008, 48:1853-1861.
27. Albertoni G.A., Arnoni C.P., Araújo P.R.B., Carvalho F.O., Barreto J.A. Signal to-cut-off (S/CO) ratio and detection of HCV genotype I by real time PCR one-step method: is there any direct relationship?. Braz J Infect Dis 2010, 14:147-152.